CAS 887401-93-6

Formel: C28H39F3N4O10S2

InChl: InChI=1S/C26H31F3N4O4.2CH4O3S/c1-37-23-6-5-19(14-30-23)25(36)10-7-21(8-11-25)33-12-9-20(16-33)32-22(34)15-31-24(35)17-3-2-4-18(13-17)26(27,28)29;2*1-5(2,3)4/h2-6,13-14,20-21,36H,7-12,15-16H2,1H3,(H,31,35)(H,32,34);2*1H3,(H,2,3,4)/t20-,21?,25?;;/m1../s1

InChI Key: PNPNUHKICDECDH-SEBNIYPMSA-N

SMILES: COC1=NC=C(C=C1)C2(CCC(CC2)N3CC[C@H](C3)NC(=O)CNC(=O)C4=CC(=CC=C4)C(F)(F)F)O.CS(=O)(=O)O.CS(=O)(=O)O

N-(2-(((R)-1-(trans-4-Hydroxy-4-(6-methoxypyridin-3-yl)cyclohexyl)pyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide dimethanesulfonate

CAS: 887401-93-6

N-(2-(((R)-1-(trans-4-Hydroxy-4-(6-methoxypyridin-3-yl)cyclohexyl)pyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide dimethanesulfonate

Formel: C₂₇H₃₅F₃N₄O₇S

Reinheit: ≥98%(HPLC)

Molekulargewicht: 616.65

Ref: 54-PC1027209

INCB 3284 dimesylate

CAS: 887401-93-6

INCB 3284 dimesylate: oral CCR2 antagonist, blocks MCP-1/hCCR2 binding (IC50: 3.7 nM), potential in acute liver failure research.

Formel: C₂₈H₃₉F₃N₄O₁₀S₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 712.76

Ref: TM-T11647